5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole has been researched along with Schizophrenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boulenguez, P; Chauveau, J; Gray, JA; Joseph, MH; Mitchell, SN; Peters, SL | 1 |
1 other study(ies) available for 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and Schizophrenia
Article | Year |
---|---|
Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
Topics: Animals; Dopamine; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Indoles; Male; Microdialysis; Microinjections; Neural Pathways; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin Receptor Agonists | 1998 |